financetom
Business
financetom
/
Business
/
EU probes AliExpress over possibly illegal, harmful online products
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EU probes AliExpress over possibly illegal, harmful online products
Mar 14, 2024 4:56 AM

BRUSSELS, March 14 (Reuters) -

Alibaba's ( BABA ) AliExpress risks a hefty fine after the

European Commission on Thursday opened an investigation into

dissemination of potentially illegal and pornographic materials,

the third such probe after X social media platform and TikTok.

The move comes under powers granted to the EU executive from

the Digital Services Act (DSA) which requires companies to do

more to tackle illegal and harmful products on their platforms.

"We are concerned that the systemic risks which have to do

with the dissemination of illegal products such as fake

medicines or non-compliant food or dietary supplements that are

not effective on AliExpress," Commission officials told

reporters.

Alibaba ( BABA ) did not immediately respond to a request for

comment.

The Commission on Thursday also sent requests for

information to Microsoft's ( MSFT ) Bing, Google Search

, Meta Platforms' ( META ) Facebook, Instagram,

Snapchat, ByteDance's TikTok and Elon Musk's X social

media platform on their use of generative artificial

intelligence.

Commission officials said they will examine whether the

companies conduct risk assessments and have risk mitigation

measures to tackle potentially harmful generative AI content.

"We are of course concerned with the harmful category,

whether it is deep fake news or election relevant, deep fakes

that seek to manipulate the public environment," the officials

said.

The Commission also sent a request for information to

Microsoft's ( MSFT ) Linkedin on the potential use of personal data for

targeted advertising following a complaint from civil society

organisations.

The probes into X and TikTok are still under way.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Atmus Filtration Q2 Adjusted Earnings, Sales Rise; 2024 Outlook Updated -- Shares Gain Pre-Bell
Atmus Filtration Q2 Adjusted Earnings, Sales Rise; 2024 Outlook Updated -- Shares Gain Pre-Bell
Aug 2, 2024
08:51 AM EDT, 08/02/2024 (MT Newswires) -- Atmus Filtration Technologies ( ATMU ) reported Q2 adjusted earnings Friday of $0.71 per diluted share, up from $0.63 a year earlier. Analysts polled by Capital IQ expected $0.58. Net sales for the quarter ended June 30 were $432.6 million, up from $413.6 million a year earlier. Analysts surveyed by Capital IQ expected...
Sector Update: Consumer
Sector Update: Consumer
Aug 2, 2024
08:48 AM EDT, 08/02/2024 (MT Newswires) -- Consumer stocks were mixed premarket Friday as the Consumer Staples Select Sector SPDR Fund (XLP) was up 0.2% and the Consumer Discretionary Select Sector SPDR Fund (XLY) fell by 3.6% recently. Church & Dwight ( CHD ) shares fell by more than 4% after the consumer goods company said it expects Q3 adjusted...
FDA Approves Adaptimmune Therapeutics' Engineered Cell Therapy As First For Solid Tumor And New Therapy For Rare Soft Tissue Cancer In Over A Decade
FDA Approves Adaptimmune Therapeutics' Engineered Cell Therapy As First For Solid Tumor And New Therapy For Rare Soft Tissue Cancer In Over A Decade
Aug 2, 2024
Thursday, the FDA approved Adaptimmune Therapeutics ( ADAP ) plc’s Tecelra (afamitresgene autoleucel) for unresectable or metastatic synovial sarcoma, a rare type of cancer that tends to occur near large joints, mainly the knees. The approval covers patients who have received prior chemotherapy, are HLA-A*02:01P, -A*02:02P, -A*02:03P, or -A*02:06P positive, and whose tumor expresses the MAGE-A4 antigen. This indication is approved under...
Plains GP Holdings Q2 Net Income Falls, Revenue Rises
Plains GP Holdings Q2 Net Income Falls, Revenue Rises
Aug 2, 2024
08:51 AM EDT, 08/02/2024 (MT Newswires) -- Plains GP Holdings ( PAGP ) reported Q2 net income Friday of $0.20 per diluted share, down from $0.25 a year earlier. Four analysts polled by Capital IQ expected $0.20. Revenue for the quarter ended June 30 was $12.93 billion, up from $11.6 billion a year earlier. Three analysts surveyed by Capital IQ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved